Clinical trial
Evaluation of Hyaluronic Acid Gel and Concentrated Growth Factor in Periodontal Therapy
NCT07932912 is registered in ClinicalTrials.gov with Amina Fouad Farag as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Hyaluronic Acid Gel and Concentrated Growth Factor in Periodontal Therapy
- Lead sponsor
- Amina Fouad Farag
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2023
- Completion date
- November 30, 2024
- Enrollment
- 66 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 3 arms.
-
Group I: MINST
Subgingival debridement under local anesthesia with 5× loupes and Gracey Mini Five curettes, using a subpapillary approach, without irrigation.
-
Group II: MINST + HA gel
MINST followed by subgingival injection of 0.8% HA gel until overflow, repeated after 4 weeks.
-
Group III: MINST + CGF
MINST followed by subgingival injection of CGF prepared from about 9 mL of venous blood (Medifuge, Silfradent), repeated after 4 weeks.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change in Clinical Attachment Level (CAL)
Distance in millimetres from the cemento-enamel junction to the base of the pocket, measured at the experimental site (the deepest interproximal pocket) with a UNC-15 probe by a calibrated examiner. CAL gain = baseline CAL minus CAL at each follow-up. The 6-month CAL gain is the main end-point; the 1- and 3-month values describe the course of attachment gain.
Lead sponsor's other trials
Amina Fouad Farag, most recent start first.
Similar trials
Same condition (Periodontitis) and phase, most recent start first.
+630 more trials See the condition page